Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
| ▸ | CA3 | P07451 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | DAO | P14920 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22349 | 0.93 | CA1 (0.67) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL2917437 | 0.93 | CA1 (0.67) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL5581302 | 0.93 | CA1 (0.67) | KMT2ACA12CA1CA2CA9 | |
| (Phenylsulfonyl)Benzene SCHEMBL6561396 | 0.91 | CA12 (0.60) | HTR6HPGDKMT2AMEN1CA12 | |
| Hydrochloric Acid SCHEMBL1338222 | 0.91 | CA1 (0.64) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL15329084 | 0.91 | CA1 (0.64) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL9134104 | 0.91 | CA1 (0.64) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL9132774 | 0.91 | CA1 (0.64) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL9131940 | 0.91 | CA1 (0.64) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL9134718 | 0.91 | CA1 (0.64) | KMT2ACA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505168-A | TPU antistatic master batch formula and method | 惠州市振有新材料科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-110437113-B | Synthesis method of 4-benzenesulfonylbenzoic acid | 苏州华道生物药业股份有限公司 | 2021-02-09 | — | — | CN | claimed |
| CN-110437113-A | A kind of synthetic method of 4- benzene sulfonyl benzoic acid | SUZHOU HUADAO BIOLOGICAL PHARMACY CO LTD | 2019-11-12 | — | — | CN | claimed |
| EP-0443742-B1 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 1997-10-01 | — | — | EP | claimed |
| US-5476754-A | Presensitized; hydrophilic surface on substrate; light sensitive layer containing alkaline water-soluble photocrosslinkable copolycondensed diazo resin | FUJI PHOTO FILM CO., LTD. (JP) | 1995-12-19 | — | — | US | claimed |
| EP-0443742-A2 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-28 | — | — | EP | claimed |
| EP-0103922-A1 | Self-extinguishing polycarbonate composition | ENICHEM TECNORESINE S.p.A. (IT) | 1984-03-28 | — | — | EP | claimed |
| EP-4559902-A2 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | Imago Biosciences Inc. (US) | 2025-05-28 | — | — | EP | disclosed |
| CN-119505168-A | TPU antistatic master batch formula and method | 惠州市振有新材料科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| EP-3256218-B1 | A KDM1A INHIBITOR AND ITS USE IN THERAPY | IMAGO BIOSCIENCES INC (US) | 2024-12-11 | — | — | EP | disclosed |
| US-20230341777-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING TERMINAL-BLOCKED REACTION PRODUCT | NISSAN CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230341777-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING TERMINAL-BLOCKED REACTION PRODUCT | NISSAN CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-11773068-B2 | KDM1A inhibitors for the treatment of disease | IMAGO BIOSCIENCES, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| EP-0443742-A2 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-28 | — | — | EP | disclosed |
| EP-0415422-A2 | Method for forming images | FUJI PHOTO FILM CO., LTD. (JP) | 1991-03-06 | — | — | EP | disclosed |
| EP-0397375-A1 | Photosensitive composition and photosensitive lithographic printing plate | KONICA CORPORATION (JP) | 1990-11-14 | — | — | EP | disclosed |
| EP-0103922-B1 | SELF-EXTINGUISHING POLYCARBONATE COMPOSITION | ENICHEM TECNORESINE S.p.A. (IT) | 1988-07-13 | — | — | EP | disclosed |
| US-4757103-A | Pyridine, biphenyl, biphenylsulfone carboxylic acid metal salts as flame retardants | ANIC, S.P.A. (IT) | 1988-07-12 | — | — | US | disclosed |
| US-4710531-A | INCLUDING A METAL OR AMMONIUM SALT OF ETHYLENE DIAMINE TETRAACETIC ACID AND A HALOGENATED ETHER COMPOUND OR POLYMER | ANIC, S.P.A. (IT) | 1987-12-01 | — | — | US | disclosed |
| EP-0103922-A1 | Self-extinguishing polycarbonate composition | ENICHEM TECNORESINE S.p.A. (IT) | 1984-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773068-B2 | KDM1A inhibitors for the treatment of disease | KDM1B, KDM1A, KDM2A | HTR6 3374/4885HPGD 1669/4885KMT2A 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.